[Skip to Content]
[Skip to Content Landing]
Views 719
Citations 0
News From the Centers for Disease Control and Prevention
September 18, 2013

HPV Vaccination Appears Stalled

JAMA. 2013;310(11):1114. doi:10.1001/jama.2013.276924

Vaccination of adolescent girls against human papilloma virus (HPV) appears to have stalled, with only about half of US girls being immunized with at least 1 dose of vaccine by age 17 years.

A recommendation to routinely vaccinate 11- or 12-year-old girls against HPV with 3 doses of vaccine was issued in 2006. Currently available quadrivalent and bivalent vaccines protect against the 2 HPV strains that cause 70% of cervical cancers. The quadrivalent vaccine also protects against 2 other virus strains that cause 90% of genital warts.